Study on the change of drug resistance and apoptosis of carcinoma cells after transfecting siRNA targeting multidrug resistance related protein
Wenli Ma
Abstract
Wenli Ma
Abstract
Aim:To study the regulation of drug resistance and the apoptosis ratio of drug resistance carcinoma cells after transfer siRNA targeting MRP. Methods: We transfected siRNA,targeting MRP(100 μmol/L),by lipofectamine into SW1575/R20(pretreated by DNR at 0.8,1.6,3.2,6.4,12.8 μg/mL),K562/ADM(pretreated by ADM at 1.6,3.2,6.4,12.8,25.6 μg/mL),and CNE2/DDP(pretreated by DDP at 0.125,0.25,0.5,1.0,2.0,4.0 μmol/mL).The negative control group is cell without any treatment,the positive control group is cell only treated by chemicaltherapy.After transfected for 6 hours,we added 20% FBS serum OPTI-MEM.The cell's viability was detected at 24,48 and 72 h by MTT method.After transfecting for 24 hours,we collected the cells to detect the mRNA level of MRP by RT-PCR.After transfecting for 48 hours,we collected the cells to detect the transfect ratio,the apoptosis ratio and the expression ratio of MRP by FCM.Results: After transfected siRNA targeting MRP and bcl-2,the level of mRNA and MRP and bcl-2 decrease significantly.Meanwhile the IC50 decreased significantly and apoptosis ratio increased significantly compared with ADM group(P0.05).For the group transfected with siRNA targeting MRP combining with bcl-2,the IC50 is the lowest and the apoptosis ratio is the highest among all groups(P0.05).Conclusion:As we transfect siRNA targeting MRP and bcl-2,the drug sensitivity and apoptosis increased with level of MRP and bcl-2 decreasing.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim:To study the regulation of drug resistance and the apoptosis ratio of drug resistance carcinoma cells after transfer siRNA targeting MRP. Methods: We transfected siRNA,targeting MRP(100 μmol/L),by lipofectamine into SW1575/R20(pretreated by DNR at 0.8,1.6,3.2,6.4,12.8 μg/mL),K562/ADM(pretreated by ADM at 1.6,3.2,6.4,12.8,25.6 μg/mL),and CNE2/DDP(pretreated by DDP at 0.125,0.25,0.5,1.0,2.0,4.0 μmol/mL).The negative control group is cell without any treatment,the positive control group is cell only treated by chemicaltherapy.After transfected for 6 hours,we added 20% FBS serum OPTI-MEM.The cell's viability was detected at 24,48 and 72 h by MTT method.After transfecting for 24 hours,we collected the cells to detect the mRNA level of MRP by RT-PCR.After transfecting for 48 hours,we collected the cells to detect the transfect ratio,the apoptosis ratio and the expression ratio of MRP by FCM.Results: After transfected siRNA targeting MRP and bcl-2,the level of mRNA and MRP and bcl-2 decrease significantly.Meanwhile the IC50 decreased significantly and apoptosis ratio increased significantly compared with ADM group(P0.05).For the group transfected with siRNA targeting MRP combining with bcl-2,the IC50 is the lowest and the apoptosis ratio is the highest among all groups(P0.05).Conclusion:As we transfect siRNA targeting MRP and bcl-2,the drug sensitivity and apoptosis increased with level of MRP and bcl-2 decreasing.
Key concepts: Lipofectamine, Transfection, Apoptosis, Multiple drug resistance, Molecular biology, Chemistry, IC50, MTT assay